Compare Becton Dickinson and Co (BDX) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Zimmer Biomet Holdings Inc — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: Becton Dickinson and Co is far larger — about 2.7× Zimmer Biomet Holdings Inc's market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | ZBH | |
|---|---|---|
Market Cap | $49.41B | $18.55B |
Sector | Health | Health |
52-Week High | $185.39 | $107.71 |
52-Week Low | $138.62 | $79.58 |
Enterprise Value | $65.51B | $25.61B |
Dividend Yield | 2.32% | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
